Autologous tumor vaccines processed to express α-gal epitopes: a practical approach to immunotherapy in cancer Uri Galili Review 16 June 2004 Pages: 935 - 945
Both soluble and membrane-bound forms of Flt3 ligand enhance tumor immunity following “suicide” gene therapy in a murine colon carcinoma model Abdul-Razzak AlsheikhlyJehad ZweiriStephen E. Christmas Original Article 04 June 2004 Pages: 946 - 954
Immunotherapy with bovine aortic endothelial cells in subcutaneous and intracerebral glioma models in rats: effects on survival time, tumor growth, and tumor neovascularization E. CorsiniM. GelatiA. Salmaggi Original Article 29 July 2004 Pages: 955 - 962
Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell–based cancer vaccination Joanna Galea-LauriJames W. WellsFarzin Farzaneh Original Article 14 May 2004 Pages: 963 - 977
Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells A. R. DadabayevM. H. SandelP. J. K. Kuppen Original Article 17 June 2004 Pages: 978 - 986
Anti-idiotype responses abrogate anti-CD4–induced tolerance to a tumor-specific antigen and promote systemic tumor immunity Ronald C. KennedyMichael H. ShearerRobert K. Bright Original Article 19 May 2004 Pages: 987 - 994
Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancer P. J. RussellK. T. OwR. Martiniello-Wilks Original Article 28 July 2004 Pages: 995 - 1004
Virosomes as new carrier system for cancer vaccines Ruth SchwaningerErnst WaeltiClaude D. Gimmi Original Article 05 June 2004 Pages: 1005 - 1017
Dendritic cells reduce number and function of CD4+CD25+ cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma Jan SchmidtSven EisoldAngela Märten Original Article 05 June 2004 Pages: 1018 - 1026
Generation of human tumor-specific CTLs in HLA-A2.1–transgenic mice using unfractionated peptides from eluates of human primary breast and ovarian tumors Angelos D. GritzapisNectaria N. SotiriadouConstantin N. Baxevanis Original Article 26 May 2004 Pages: 1027 - 1040
CRM197 (nontoxic diphtheria toxin): effects on advanced cancer patients Silvio BuzziDiego RubboliFlavio Pironi Original Article 28 May 2004 Pages: 1041 - 1048
Lower percentages of monocytes with CD80, CD86 and HLA-DR molecule expression in pediatric cancer Wlodzimierz LuczynskiAnna Stasiak-BarmutaMaryna Krawczuk-Rybak Letter to the Editors 29 July 2004 Pages: 1049 - 1050
Altered surface expression patterns of circulating monocytes in cancer patients: impaired capacity of T-cell stimulation? Selma UgurelMonika LindemannHans Grosse-Wilde Letter to the Editors 30 June 2004 Pages: 1051 - 1051
Cancer gene therapy: new horizons in the East Farzin FarzanehNagy HabibPeter Walden Meeting Report 03 July 2004 Pages: 1052 - 1053
